Source: Pharmabiz

DSN: Clinigen to acquire USbased pharmacovigilance service provider, Drug Safety Navigator

Clinigen Limited, the global pharmaceutical services company, has agreed to acquire Drug Safety Navigator Inc. (DSN), a specialist pharmacovigilance service provider based in the US. This acquisition

Read full article »

DSN's Competitors | DSN's News | DSN's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

President

Molly James

CEO Approval Rating

84/100

DSN is a North Carolina-based company that provides services such as safety signal detection, pharmacovigilance, and adverse event reporting for the healthcare sector.